1193870006: Niraparib tosylate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Glycosyltransferase inhibitor\Pentosyltransferase inhibitor\Nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor\Niraparib tosylate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Niraparib tosylate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Piperazine and/or piperazine derivative (substance)\Piperazine derivative\Niraparib tosylate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4688933015 Niraparib tosylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4688934014 Niraparib tosylate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Niraparib tosylate	Is a	Piperazine derivative	true	Inferred relationship	Some
Niraparib tosylate	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some
Niraparib tosylate	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Niraparib tosylate	Is a	Nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor	true	Inferred relationship	Some
Niraparib tosylate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor (disposition)	true	Inferred relationship	Some
Niraparib tosylate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Niraparib (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Niraparib (as niraparib tosylate) 100 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Niraparib tosylate	Inferred relationship	Some	1
Niraparib tosylate monohydrate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Niraparib tosylate	Inferred relationship	Some
Niraparib tosylate anhydrous	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Niraparib tosylate	Inferred relationship	Some

This concept is not in any reference sets